Journal of agricultural medicine and community health (농촌의학ㆍ지역보건)

Korean Society for Rural Medicine and Community Health (한국농촌의학지역보건학회)
권호 표지
DOI QR코드

DOI QR Code

Predictors of Persistence and Adherence with Secondary Preventive Medication in Stroke Patients

지역사회 뇌졸중 환자들의 이차 예방을 위한 치료 지속률과 약물 순응도 관련 요인

  • Kim, Young Taek (Division of Infectious Disease Control, Centers for Infectious Disease Control, Korea Centers for Disease Control and Prevention) ;
  • Park, Ki Soo (Department of Preventive Medicine and Institute of Health Sciences, School of Medicine, Gyeongsang National University) ;
  • Bae, Sang-Geun (Department of Preventive Medicine, School of Medicine, Kyungpook National University)
  • 김영택 (질병관리본부 감염병관리과) ;
  • 박기수 (경상대학교 의과대학 예방의학교실 및 건강과학연구원) ;
  • 배상근 (경북대학교 의과대학 예방의학교실)
  • Received : 2015.02.23
  • Accepted : 2015.03.12
  • Published : 2015.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study aimed to explore the persistence and adherence to secondary preventive medication of stroke patients after discharge and to assess the reasons for persistence and nonadherence. Methods: Four hundred twenty-nine patients with stroke were surveyed to determine their behaviors from discharge. Reasons for stopping medications were ascertained. Persistence was defined as continuation of all secondary preventive medications prescribed at hospital discharge, and adherence as continuation of prescribed medications according to health care provider instructions. Results: Of the 429 patients, 86.5% were treatment persistent and 41.2%(non-intentional nonadherence=39.4%, intentional nonadherence=19.4%) were adherent. Independent predictors of persistence included having experience about health education. Independent predictors of non-intentional nonadherence were modified Rankin Scale(mRS) (Exp(B)=2.858, p=0.001) and health education experience (Exp(B)=0.472, p=0.032), and independent predictors of intentional nonadherence were mRS (Exp(B)=2.533, p=0.006), depressive symptoms (Exp(B)=1.113, p=0.016), beliefs about medications questionnaire(necessity, Exp(B)=0.879, p=0.011, concern, Exp(B)=1.098, p=0.019). Conclusions: Although up to one-ninth of stroke patients continued secondary prevention medications, nonadherence is common. Several potentially modifiable patient, provider, and system-level factors associated with persistence and adherence may be targets for future interventions. Specially, interventions to improve adherence should target patients' beliefs about their medication.

지역사회 뇌졸중환자들의 치료 지속률과 약물 순응도에 대한 연구는 아직 많이 실시되지 않았다. 그러나 치료 지속률과 약물 순응도가 뇌졸중의 재발 및 사망과 밀접한 관련이 있다는 것은 많이 알려진 사실이다. 이에 본 연구는 지역에 거주하고 있는 뇌졸중환자들을 임의 추출하여 이들의 치료 지속률과 약물 순응도를 평가하고 이에 영향을 미치는 요인을 찾기 위하여 실시되었다. 연구대상자는 429명으로 이들의 뇌졸중 치료율과 현재 복용하고 있는 약물의 순응률을 파악하였으며 약물 순응도는 의도적 비순응군과 비의도적 비순응군으로 구분하여 조사하였다. 연구 결과 치료 지속률은 86.5%였으며 이들 중 약물 순응도는 41.2%였다. 치료 지속률에 영향을 미치는 요인으로는 보건교육 경험뿐이었으며, 비의도적 약물 비순응에 영향을 미치는 요인은 mRS와 보건교육 경험 그리고 의도적 약물 비순응에 영향을 미치는 요인은 mRS와 우울감 정도 그리고 약물에 대한 신념(필요성, 염려)이었다. 결론적으로 지역사회 뇌졸중환자의 재발방지와 사망률감소를 위하여 약물복용을 중요하게 교육하여야 할 것이며 순응도 향상을 위해서는 약물에 대한 필요성은 올리고 염려 수준을 낮추도록 교육하여야 할 것이다.

Keywords

References

  1. Statistics Korea. Annual Report on The Causes of Death Statistics. available from http://kostat.go.kr/portal/korea/kor_nw/2/6/2/index.board (Korean)
  2. Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 2011;42(5):1489-1494 https://doi.org/10.1161/STROKEAHA.110.602615
  3. Antiplatelet Trialist's Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988;296(6618):320-331 https://doi.org/10.1136/bmj.296.6618.320
  4. Antiplatelet Trialist's Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308(6921):81-106 https://doi.org/10.1136/bmj.308.6921.81
  5. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 2004;35(12):2879-2883 https://doi.org/10.1161/01.STR.0000147967.49567.d6
  6. Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis 2008;17(1):5-8 https://doi.org/10.1016/j.jstrokecerebrovasdis.2007.09.004
  7. Bushnell C, Zimmer L, Schwamm L, Goldstein LB, Clapp-Channing N, Harding T, Drew L, Zhao X, Peterson E; AVAIL registry. The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. Am Heart J 2009;157(3):428-435 https://doi.org/10.1016/j.ahj.2008.11.002
  8. Bushnell CD1, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, Alberts MJ, Fagan SC, Fonarow GC, Johnston SC, Kidwell C, Labresh KA, Ovbiagele B, Schwamm L, Peterson ED; AVAIL Investigators. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 2011;77(12):1182-905. https://doi.org/10.1212/WNL.0b013e31822f0423
  9. Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: A comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud 2007;44(8):1468-77 https://doi.org/10.1016/j.ijnurstu.2006.07.010
  10. Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: A challenge for tailored interventions. Patient Prefer Adherence 2013;7:675
  11. Wroe AL. Intentional and unintentional nonadherence: A study of decision making. J Behav Med 2002;25(4):355-372 https://doi.org/10.1023/A:1015866415552
  12. Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 2005;39(7-8):1198-1203 https://doi.org/10.1345/aph.1E594
  13. Lehane E, McCarthy G. An examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertension. J Clin Nurs 2007; 16(4):698-706 https://doi.org/10.1111/j.1365-2702.2005.01538.x
  14. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One 2013;8(12):e80633 https://doi.org/10.1371/journal.pone.0080633
  15. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47(6):555-567. https://doi.org/10.1016/S0022-3999(99)00057-4
  16. Jung JH, Kim YH, Han DJ, Kim KS, Chu SH. Medication Adherence in Patients Taking Immunosuppressants after Kidney Transplantation. J Korean Soc Transplant 2010;24(4):289-297 (Korean) https://doi.org/10.4285/jkstn.2010.24.4.289
  17. Lee JK. Factors associated with drug misuse behaviors among polypharmacy elderly. Korean J Adult Nurs 2011;23(6):554-563 (Korean)
  18. Hong KS. Measuring and analysis of outcome in stroke trials. Korean J Stroke 2011;13(1):1-10 (Korean) https://doi.org/10.5853/kjs.2011.13.1.1
  19. Kang H. A guide on the use of factor analysis in the assessment of construct validity. J Korean Acad Nurs 2013;43(5):587-594 (Korean) https://doi.org/10.4040/jkan.2013.43.5.587
  20. Lubben J1, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, Stuck AE. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist 2006;46(4):503-513. https://doi.org/10.1093/geront/46.4.503
  21. Hong M, Casado BL, Harrington D. Validation of Korean versions of the Lubben social network scales in Korean Americans. Clinical gerontologist 2011;34(4):319-334 https://doi.org/10.1080/07317115.2011.572534
  22. Ki BS. A preliminary study for the standardization of geriatric depression scale short form-Korea version. J Korean Neuropsychatr Assoc 1996;35(2):298-307 (Korean)
  23. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-497 https://doi.org/10.1056/NEJMra050100
  24. Koh IS, Kim HC, Kwon SB, Hwang SH, Kwon KH, Kim SM, Song HK, Lee BC. The compliance of stroke patients for secondary prevention : In Seoul & Kyunggi Province J Kor Neurol Ass 1999;17(4):472-477 (Korean)
  25. Lummis HL1, Sketris IS, Gubitz GJ, Joffres MR, Flowerdew GJ. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurol 2008;8:25 https://doi.org/10.1186/1471-2377-8-25
  26. Jang SH, Kang PS, Lee KS, Kim SB, Yun SH. Change in health behaviors of patients before and after stroke. Korean J of Rural Med 2002;27(1):9-19 (Korean)
  27. Kim SO. Medication adherence of elderly with hypertension and/or diabetes-mellitus and its' influencing factors. Kor J Clin Pharm 2011;21(2):81-89 (Korean)
  28. Kirkpatrick AC, Vincent AS, Guthery L, Prodan CI. Cognitive impairment is associated with medication nonadherence in asymptomatic carotid stenosis. Am J Med 2014;127(12):1243-1246 https://doi.org/10.1016/j.amjmed.2014.08.010
  29. Ji R, Liu G, Shen H, Wang Y, Li H, Peterson E, Wang Y. Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry. Neurol Res 2013;35(1):29-36 https://doi.org/10.1179/1743132812Y.0000000107
  30. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160(14):2101-2107 https://doi.org/10.1001/archinte.160.14.2101
  31. Leventhal H, Weinman J, Leventhal EA, Phillips LA. Health psychology: The search for pathways between behavior and health. Annu Rev Psychol 2008;59:477-505 https://doi.org/10.1146/annurev.psych.59.103006.093643

Cited by

  1. Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception vol.33, pp.1, 2018, https://doi.org/10.3904/kjim.2015.383
  2. Comparison of Motivation for Rehabilitation, Family Support and Adherence to Rehabilitation between Depressive and Non-depressive Stroke Patients vol.19, pp.2, 2016, https://doi.org/10.7587/kjrehn.2016.138
  3. Response to comment on “Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception” vol.33, pp.6, 2018, https://doi.org/10.3904/kjim.2018.269